Skin Cancers Terminated Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

DBCOND0046599 (Skin Cancers)Terminated2 IdentifierTitlePurposeDrugs
NCT01369875Modified Tumor Infiltrating Lymphocytes for Metastatic MelanomaTreatment
NCT02111863Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaTreatment
NCT00509496Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered LymphocytesTreatment
NCT00610311Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced MelanomaTreatment
NCT00612222Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced MelanomaTreatment
NCT01495572Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor CellsTreatment